Contracts › 75A50325F80009
75A50325F80009: Doxycycline Hyclate 100 Mg Oral Tablets
Awarded to Chartwell Rx Llc by Office of Assistant Secretary for Preparedness and Response.
$144.6Mobligated
$168.0Mpotential value
22 June 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75A50325F80009 |
|---|---|
| Vehicle | 36F79720D0198 |
| Awardee | Chartwell Rx Llc |
| Awarding agency | Office of Assistant Secretary for Preparedness and Response |
| Awarding office | ASPR/ORM-SNS |
| NAICS | 325412 Pharmaceutical Preparation Manufacturing |
| PSC | 6505 Drugs and Biologicals |
| Place of performance | NY |
| Offers received | 2 |
| Period of performance | 23 June 2025 to 22 June 2027 |
| Potential end | 22 June 2029 |
| Estimated recompete solicitation | ~Q4 2026 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 325412 contracts · All expiring contracts · USASpending record